World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000007419
Date of registration: 01/04/2012
Prospective Registration: Yes
Primary sponsor: Department of Orthopedic Surgery Kobe University Graduate School of Medicine
Public title: A Prospective, Randomized, Multicenter Trial of Pregabalin and Celecoxib for Lumbar Spinal Stenosis
Scientific title: A Prospective, Randomized, Multicenter Trial of Pregabalin and Celecoxib for Lumbar Spinal Stenosis - A Prospective, Randomized, Multicenter Trial of Pregabalin and Celecoxib for Lumbar Spinal Stenosis
Date of first enrolment: 2012/04/01
Target sample size: 80
Recruitment status: Pending
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008738
Study type:  Interventional
Study design:  Parallel Randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Koichiro Maeno
Address:  7-5-2 Kusunoki-cyo Cyuou-ku Kobe-city Hyogo-prefecture Japan Japan
Telephone: 078-382-5985
Email: takada-t@hokuto-hp.or.jp
Affiliation:  Kobe university Graduate School of Medicine Department of Orthopedic Surgery
Name:     Koichiro Maeno
Address:  7-5-2 Kusunoki-cyo Cyuou-ku Kobe-city Hyogo-prefecture Japan Japan
Telephone: 078-382-5985
Email: takada-t@hokuto-hp.or.jp
Affiliation:  Kobe university Graduate School of Medicine Department of Orthopedic Surgery
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: Arteriosclerosis obliterans Diabetic neuropathy Anterior tibial muscle MMT 3 and below Ineffectiveness of epidural block over 3 times in a month Vesicorectal disturbance Heart failure Herniated disc disase

Age minimum: 50years-old
Age maximum: 90years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Lumbar Spinal Stenosis
Intervention(s)
Celecoxib
Pregabalin
Primary Outcome(s)
The recovery of pain and ADL four weeks after the administration
Secondary Outcome(s)
The recovory of NRS, ODI, SF-36 score four weeks after the administration
Secondary ID(s)
Source(s) of Monetary Support
Department of Orthopedic Surgery Kobe University Graduate School of Medicine
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history